We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Investigational therapy inhibits production of ...
In a small, short-term, Phase 2 clinical trial in adults, a first-of-its-kind medication reduced triglyceride levels in most patients by more than 60%. Called DR10624, the medication activates three ...
In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results